These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 18006855

  • 1. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
    Raina K, Blouin MJ, Singh RP, Majeed N, Deep G, Varghese L, Glodé LM, Greenberg NM, Hwang D, Cohen P, Pollak MN, Agarwal R.
    Cancer Res; 2007 Nov 15; 67(22):11083-91. PubMed ID: 18006855
    [Abstract] [Full Text] [Related]

  • 2. Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice.
    Raina K, Singh RP, Agarwal R, Agarwal C.
    Cancer Res; 2007 Jun 15; 67(12):5976-82. PubMed ID: 17575168
    [Abstract] [Full Text] [Related]

  • 3. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
    Singh RP, Deep G, Blouin MJ, Pollak MN, Agarwal R.
    Carcinogenesis; 2007 Dec 15; 28(12):2567-74. PubMed ID: 17916909
    [Abstract] [Full Text] [Related]

  • 4. Prostate cancer chemoprevention by silibinin: bench to bedside.
    Singh RP, Agarwal R.
    Mol Carcinog; 2006 Jun 15; 45(6):436-42. PubMed ID: 16637061
    [Abstract] [Full Text] [Related]

  • 5. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA, Narayanan NK, Pittman B, Reddy BS.
    Clin Cancer Res; 2004 Nov 15; 10(22):7727-37. PubMed ID: 15570007
    [Abstract] [Full Text] [Related]

  • 6. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.
    Gupta S, Ahmad N, Marengo SR, MacLennan GT, Greenberg NM, Mukhtar H.
    Cancer Res; 2000 Sep 15; 60(18):5125-33. PubMed ID: 11016639
    [Abstract] [Full Text] [Related]

  • 7. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
    Singh RP, Sharma G, Dhanalakshmi S, Agarwal C, Agarwal R.
    Cancer Epidemiol Biomarkers Prev; 2003 Sep 15; 12(9):933-9. PubMed ID: 14504208
    [Abstract] [Full Text] [Related]

  • 8. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ, Mohan S, Cohen P, Foster BA, Greenberg NM.
    Cancer Res; 1999 May 01; 59(9):2203-9. PubMed ID: 10232609
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: relationship with silibinin levels.
    Verschoyle RD, Greaves P, Patel K, Marsden DA, Brown K, Steward WP, Gescher AJ.
    Eur J Cancer; 2008 Apr 01; 44(6):898-906. PubMed ID: 18343654
    [Abstract] [Full Text] [Related]

  • 10. Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels.
    Singh RP, Dhanalakshmi S, Tyagi AK, Chan DC, Agarwal C, Agarwal R.
    Cancer Res; 2002 Jun 01; 62(11):3063-9. PubMed ID: 12036915
    [Abstract] [Full Text] [Related]

  • 11. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
    Deep G, Singh RP, Agarwal C, Kroll DJ, Agarwal R.
    Oncogene; 2006 Feb 16; 25(7):1053-69. PubMed ID: 16205633
    [Abstract] [Full Text] [Related]

  • 12. Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model.
    Raghow S, Kuliyev E, Steakley M, Greenberg N, Steiner MS.
    Cancer Res; 2000 Aug 01; 60(15):4093-7. PubMed ID: 10945615
    [Abstract] [Full Text] [Related]

  • 13. Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling.
    Mallikarjuna G, Dhanalakshmi S, Singh RP, Agarwal C, Agarwal R.
    Cancer Res; 2004 Sep 01; 64(17):6349-56. PubMed ID: 15342425
    [Abstract] [Full Text] [Related]

  • 14. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer.
    Adhami VM, Siddiqui IA, Ahmad N, Gupta S, Mukhtar H.
    Cancer Res; 2004 Dec 01; 64(23):8715-22. PubMed ID: 15574782
    [Abstract] [Full Text] [Related]

  • 15. Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
    Raina K, Rajamanickam S, Singh RP, Deep G, Chittezhath M, Agarwal R.
    Cancer Res; 2008 Aug 15; 68(16):6822-30. PubMed ID: 18701508
    [Abstract] [Full Text] [Related]

  • 16. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
    Harper CE, Patel BB, Wang J, Eltoum IA, Lamartiniere CA.
    Prostate; 2007 Oct 01; 67(14):1576-89. PubMed ID: 17705241
    [Abstract] [Full Text] [Related]

  • 17. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP).
    Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, Elgavish A.
    Cancer Res; 2001 Sep 15; 61(18):6777-82. PubMed ID: 11559550
    [Abstract] [Full Text] [Related]

  • 18. Silibinin prevents ultraviolet radiation-caused skin damages in SKH-1 hairless mice via a decrease in thymine dimer positive cells and an up-regulation of p53-p21/Cip1 in epidermis.
    Dhanalakshmi S, Mallikarjuna GU, Singh RP, Agarwal R.
    Carcinogenesis; 2004 Aug 15; 25(8):1459-65. PubMed ID: 15033902
    [Abstract] [Full Text] [Related]

  • 19. 2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6.
    Garcia GE, Wisniewski HG, Lucia MS, Arevalo N, Slaga TJ, Kraft SL, Strange R, Kumar AP.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 1):980-8. PubMed ID: 16467113
    [Abstract] [Full Text] [Related]

  • 20. OSU-HDAC42, a histone deacetylase inhibitor, blocks prostate tumor progression in the transgenic adenocarcinoma of the mouse prostate model.
    Sargeant AM, Rengel RC, Kulp SK, Klein RD, Clinton SK, Wang YC, Chen CS.
    Cancer Res; 2008 May 15; 68(10):3999-4009. PubMed ID: 18483287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.